Search

Palanichamy Ilankumaran

from Montville, NJ
Age ~55

Palanichamy Ilankumaran Phones & Addresses

  • 6 Eberhardt Ct, Montville, NJ 07045 (973) 809-7539
  • 1800 Rachel Ter, Pine Brook, NJ 07058 (973) 227-2199
  • 1800 Rachel Ter APT 3, Pine Brook, NJ 07058
  • 122 Cedar Ave, Highland Park, NJ 08904 (732) 448-0508
  • Rockville, MD
  • Siletz, OR
  • Ames, IA

Work

Company: Novartis oncology May 2020 Position: Senior clinical development director

Education

Degree: Doctorates, Doctor of Philosophy School / High School: Indian Institute of Science (Iisc) 1991 to 1997

Skills

Clinical Trials • Clinical Development • Biotechnology • Drug Discovery • Pharmaceutical Industry

Industries

Pharmaceuticals

Resumes

Resumes

Palanichamy Ilankumaran Photo 1

Senior Clinical Development Director

View page
Location:
1800 Rachel Ter, New Jersey
Industry:
Pharmaceuticals
Work:
Novartis Oncology
Senior Clinical Development Director

Sk Life Science, Inc. Feb 2002 - Jan 2016
Director, Clinical Development
Education:
Indian Institute of Science (Iisc) 1991 - 1997
Doctorates, Doctor of Philosophy
Madurai Kamaraj University 1989 - 1991
Master of Science, Masters
Skills:
Clinical Trials
Clinical Development
Biotechnology
Drug Discovery
Pharmaceutical Industry

Publications

Us Patents

Substituted Carboxylic Acid Derivatives For The Treatment Of Diabetes And Lipid Disorders, Their Preparation And Use

View page
US Patent:
20060281802, Dec 14, 2006
Filed:
Mar 28, 2006
Appl. No.:
11/391031
Inventors:
Yong Choi - Pinebrook NJ, US
Hunwoo Shin - Livingston NJ, US
Palanichamy Ilankumaran - Pinebrook NJ, US
International Classification:
A61K 31/4184
C07D 235/12
US Classification:
514394000, 548310100
Abstract:
The present invention is concerned with racemic or enantiomerically enriched substituted carboxylic acids and derivatives thereof represented by Formula 1; or pharmaceutically acceptable salts thereof. The present invention also includes pharmaceutical compositions comprising an effective amount of a compound of Formula 1 in admixture with a pharmaceutically acceptable carrier or excipient. The compositions may include additional therapeutic agents for combination therapy. The present invention provides a new class of pharmaceutically active compounds, which are useful in the treatment and control of diabetes and its related metabolic diseases.
Palanichamy Ilankumaran from Montville, NJ, age ~55 Get Report